Genetic/familial high-risk assessment: Breast and ovarian, version 1.2014 Journal Article
| Authors: | Daly, M. B.; Pilarski, R.; Axilbund, J. E.; Buys, S. S.; Crawford, B.; Friedman, S.; Garber, J. E.; Horton, C.; Kaklamani, V.; Klein, C.; Kohlmann, W.; Kurian, A.; Litton, J.; Madlensky, L.; Marcom, P. K.; Merajver, S. D.; Offit, K.; Pal, T.; Pasche, B.; Reiser, G.; Shannon, K. M.; Swisher, E.; Voian, N. C.; Weitzel, J. N.; Whelan, A.; Wiesner, G. L.; Dwyer, M. A.; Kumar, R. |
| Article Title: | Genetic/familial high-risk assessment: Breast and ovarian, version 1.2014 |
| Abstract: | During the past few years, several genetic aberrations that may contribute to increased risks for development of breast and/ or ovarian cancers have been identified. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian focus specifically on the assessment of genetic mutations in BRCA1/BRCA2, TP53, and PTEN, and recommend approaches to genetic testing/counseling and management strategies in individuals with these mutations. This portion of the NCCN Guidelines includes recommendations regarding diagnostic criteria and management of patients with Cowden Syndrome/ PTEN hamartoma tumor syndrome. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 12 |
| Issue: | 9 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2014-09-01 |
| Start Page: | 1326 |
| End Page: | 1338 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 25190698 |
| DOI/URL: | |
| Notes: | Export Date: 3 November 2014 -- Source: Scopus |
